Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115207) titled 'Research on the Pathogenic Mechanism of Mannosyltransferase ALG3 Affecting Glycosylation in Extravillous Trophoblasts in Preeclampsia' on Dec. 23, 2025.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: Hainan Medical College First Affiliated Hospital
Condition:
Preeclampsia
Intervention:
Preeclampsia patients group:NA
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Preeclampsia patients group:20;Normal pregnant women group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=...